RapidAI experiences nearly 300% growth


RapidAI, a neuroimaging stroke software platform which uses artificial intelligence (AI), has announced growth of nearly 300%. This has been attributed by RapidAI in a press release to an ”international adoption” of AI-powered stroke care.

RapidAI is approved for use in over 60 countries, used in over 1,600 hospitals, and is on track to scan one million patients worldwide by the end of 2020.

Sanjeev Nayak, University Hospitals of North Midlands, UK, comments: “I see artificial intelligence as the future in the fast-moving world of diagnostic and therapeutic stroke management.”


Please enter your comment!
Please enter your name here